Extraprise

Website Links

Description

Ann Stanesa joined Feinstein Kean Healthcare in 2011 with more than 15 years of experience in communications and marketing roles focused in the biotech, pharmaceutical and legislative areas. As a senior vice president, Ann applies her expertise in thought leadership development, crisis communications, public affairs, advocacy development, government relations, and corporate communications to address the critical issues affecting clients. Current clients include Organogenesis, the Biotech Industry Organization (BIO), BG Medicine, Moderna, and Arsenal Medical/480 Biomedical.

Christine has nearly twenty years of experience in B2B marketing communications and media relations for life sciences organizations.

At Feinstein Kean, we work with organizations that reside where the science, technology and business of healthcare intersect. Our clients are driving revolutionary transformation in biomedicine through major advances in health technology (HIT, Bioinformatics, Medical Devices and Diagnostics). We also work with market leaders that are shaping the way in which healthcare services are accessed, financed and measured — including organizations such as health plans, disease management organizations, health systems and healthcare providers.

Jennifer’s work includes the launch and support of the National Cancer Institute’s advanced technology initiatives in nanotechnology, proteomics, genomics, and bioinformatics. She also provides counsel to associations and government entities, managing policy and communications campaigns dedicated to translating for diverse audiences the story of how innovations in science and technology are shaping our understanding of disease, our health interventions, and our health care delivery systems.

Robert McBurney joined the Accelerated Cure Project for Multiple Sclerosis as its Chief Executive in mid-2011 because he was compelled by the organization’s novel approach to catalyzing innovation in research towards a cure for MS.He is a neuroscientist by training and has over 35 years of experience in biomedical research and in the management of research-based biotech companies.

Fact sheet

Company contacts

Companies nearby